Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-21,727
Closed -$334K 4801
2025
Q3
$334K Sell
21,727
-149,893
-87% -$2.42M ﹤0.01% 3580
2025
Q2
$2.7M Buy
171,620
+129,228
+305% +$1.96M ﹤0.01% 1877
2025
Q1
$810K Sell
42,392
-20,222
-32% -$442K ﹤0.01% 2852
2024
Q4
$1.49M Buy
+62,614
New +$1.75M ﹤0.01% 2685
2023
Q3
Sell
-15,191
Closed -$344K 4185
2023
Q2
$344K Sell
15,191
-77,997
-84% -$1.57M ﹤0.01% 2880
2023
Q1
$1.83M Buy
93,188
+68,168
+272% +$1.31M 0.01% 1480
2022
Q4
$430K Buy
+25,020
New +$444K ﹤0.01% 2368

Other funds holding RXO

Squarepoint's RXO Position: Q4 2025 in Review

Squarepoint sold out of RXO (RXO) in Q4 2025, closing a stake of 21,727 shares — an estimated $334K sold.

Squarepoint first reported a position in RXO in Q4 2022 and held it in 7 quarters. The position peaked at $2.7M in Q2 2025. 268 funds tracked by Wall St. Rank hold RXO as of Q4 2025.

  • Squarepoint reported no remaining RXO position as of Q4 2025 after selling out during the quarter.
  • Squarepoint sold 21,727 RXO shares in Q4 2025, an estimated $334K.
  • Squarepoint first reported a position in RXO in Q4 2022 and held it in 7 quarters.
  • Squarepoint's RXO position peaked at $2.7M in Q2 2025.
  • 268 funds tracked by Wall St. Rank held RXO as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.